0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover299.71%IV40.76%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1451Delta0.0341Gamma11.25Leverage Ratio-0.0297Theta-0.0012Rho-1.63Eff Leverage0.0051Vega
Voyager Therapeutics Stock Discussion
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease
Stocks declined for a second day, weighed down by declines in tech giants that previously lifted major indices higher in 2023.
The tech-heavy $Nasdaq Composite Index(.IXIC.US)$ lost 1.2% to 14,592.21, building on its worst daily performance since October. The $S&P 500 Index(.SPX.US)$ declined 0.8% to 4,704.81, while the $Dow Jones Industrial Average(.DJI.US)$ fell 0.8% to 37,430.19.
Software stocks tracked by moomoo slid...
No comment yet